Search results
Results from the WOW.Com Content Network
"Happy Science", a secretive pay-to-progress religious group, sells "spiritual vaccines" to prevent and cure COVID-19, advertises virus-related blessings at rates from US$100 to over US$400, and sells coronavirus-themed DVDs and CDs of Ryuho Okawa (the former stockbroker whom the group believes to be the current incarnation of the supreme deity ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Coronavirus disease 2019 (COVID-19) Yes: Coxsackie B virus: Coxsackie B virus infection Enterovirus infection is diagnosed mainly via serological tests such as ELISA and from cell culture. There is no well-accepted treatment for the Coxsackie B group of viruses. Under research [10] PRNP
Part of a series on the COVID-19 pandemic Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom. COVID-19 (disease) SARS-CoV-2 (virus) Cases Deaths Timeline 2019 2020 January responses February responses March responses April responses May responses June responses July responses August responses September responses October responses November ...
Coronavirus diseases are caused by viruses in the coronavirus subfamily, a group of related RNA viruses that cause diseases in mammals and birds. In humans and birds, the group of viruses cause respiratory tract infections that can range from mild to lethal.
One of the most notable scientific papers that first popularized hydroxychloroquine as a COVID-19 treatment was retracted from its journal due to ethical and methodological issues. Retractions in ...
Coronavirus disease 2019 (COVID-19) Viral Unvaccinated & Treated with unspecific treatments: 0.5-2% Depends largely on the age group of the person, earlier strains of COVID-19 had higher CFR of around 2%. [53] [54] [55] Lassa fever: Viral Treated ≈1% 15% in hospitalized patients; higher in some epidemics. [56] Mumps encephalitis: Viral ...
This registry based, multi-center, multi-country data provide provisional support for the use of ECMO for COVID-19 associated acute hypoxemic respiratory failure. Given that this is a complex technology that can be resource intense, guidelines exist for the use of ECMO during the COVID-19 pandemic. [85] [86] [87]
The Solidarity trial for treatments is a multinational Phase III-IV clinical trial organized by the World Health Organization (WHO) and partners to compare four untested treatments for hospitalized people with severe COVID-19 illness.